Table 1 Basic patient information
From: Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model
Clinical feature | Category | N / Mean ± Std |
|---|---|---|
Sex | Male | 87 |
Female | 18 | |
Age (year) |  | 67.28 ± 8.57 |
BMI (kg/m2) |  | 22.40 ± 3.11 |
BSA (m2) |  | 1.62 ± 0.15 |
HGB (g/l) |  | 125.29 ± 16.89 |
CA72-4 (IU/ml) |  | 8.20 ± 22.20 |
CYFRA21-1 (ng/ml) |  | 9.09 ± 29.39 |
SCC (ng/ml) |  | 4.08 ± 9.79 |
CEA (ng/ml) |  | 2.83 ± 2.02 |
CA19-9 (U/ml) |  | 14.76 ± 33.24 |
LL(cm) |  | 7.68 ± 2.81 |
MDL(cm) |  | 3.60 ± 1.23 |
T stage | T1-2 | 20 |
T3 | 74 | |
T4 | 11 | |
N stage | N0 | 25 |
N1 | 25 | |
N2-3 | 55 | |
M stage | M0 | 105 |
TNM Stage | II | 29 |
III | 63 | |
IVA | 13 |